IR CANCELLED; US REGISTRATION CANCELLED
on 05 Apr 2024
Last Applicant/ Owned by
F-92100 BOULOGNE BILLANCOURT
FR
Serial Number
79146282 filed on 04th Apr 2014
Registration Number
4623099 registered on 21st Oct 2014
Correspondent Address
William S. Frommer, Esq.
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
TARMIQRA
Pharmaceutical preparations for use in the prevention, treatment, and cure of oncological, endocrine, neurological, hematological, gastroenterological, and urological conditions and diseases and for the prevention, treatment, and cure of cardiovascular and cognitive disorders
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for use in the prevention, treatment, and cure of oncological, endocrine, neurological, hematological, gastroenterological, and urological conditions and diseases and for the prevention, treatment, and cure of cardiovascular and cognitive disorders
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79146282
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 18th Oct 2024 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED |
| 18th Oct 2024 | DEATH OF INTERNATIONAL REGISTRATION |
| 11th Jul 2022 | TOTAL INVALIDATION PROCESSED BY THE IB |
| 09th May 2022 | INVALIDATION PROCESSED |
| 09th May 2022 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| 07th Jan 2022 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
| 07th May 2021 | CANCELLED SECTION 71 |
| 19th Jun 2020 | REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD |
| 13th May 2020 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 10th Mar 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |